Related Experiment Video
Updated: Aug 9, 2025

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
Gatekeeper mutations activate FGF receptor tyrosine kinases by destabilizing the autoinhibited state
Alida Besch1, William M Marsiglia1, Moosa Mohammadi2
1Department of Chemistry, New York University, New York, NY 10003.
Abstract:
Many types of human cancers are being treated with small molecule ATP-competitive inhibitors targeting the kinase domain of receptor tyrosine kinases. Despite initial successful remission, long-term treatment almost inevitably leads to the emergence of drug resistance mutations at the gatekeeper residue hindering the access of the inhibitor to a hydrophobic pocket at the back of the ATP-binding cleft. In addition to reducing drug efficacy, gatekeeper mutations elevate the intrinsic activity of the tyrosine kinase domain leading to more aggressive types of cancer. However, the mechanism of gain-of-function by gatekeeper mutations is poorly understood. Here, we characterized fibroblast growth factor receptor (FGFR) tyrosine kinases harboring two distinct gatekeeper mutations using kinase activity assays, NMR spectroscopy, bioinformatic analyses, and MD simulations. Our data show that gatekeeper mutations destabilize the autoinhibitory conformation of the DFG motif locally and of the kinase globally, suggesting they impart gain-of-function by facilitating the kinase's ability to populate the active state.
Insights
Gatekeeper mutations in tyrosine kinases, often found in cancer drug resistance, boost kinase activity. These mutations destabilize the kinase, promoting its active state and leading to more aggressive cancers.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Small molecule ATP-competitive inhibitors target receptor tyrosine kinases for cancer treatment.
- Gatekeeper mutations in tyrosine kinases confer drug resistance and increase cancer aggressiveness.
- The gain-of-function mechanism of gatekeeper mutations remains poorly understood.
Purpose of the Study:
- To investigate the mechanism by which gatekeeper mutations in fibroblast growth factor receptor (FGFR) tyrosine kinases lead to enhanced activity.
- To elucidate how these mutations contribute to cancer progression and drug resistance.
Main Methods:
- Kinase activity assays
- Nuclear Magnetic Resonance (NMR) spectroscopy
- Bioinformatic analyses
- Molecular Dynamics (MD) simulations
Main Results:
- Gatekeeper mutations were found to destabilize the autoinhibitory conformation of the DFG motif.
- These mutations globally destabilize the tyrosine kinase domain.
- The destabilization facilitates the kinase's transition to and population of the active state.
Conclusions:
- Gatekeeper mutations confer gain-of-function by promoting the active conformation of tyrosine kinases.
- Understanding this mechanism is crucial for developing strategies to overcome drug resistance in cancer therapy.
More Related Videos
09:13Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases
Published on: November 22, 2024
07:32Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library
Published on: September 30, 2019
Related Concept Videos
Amplifying Signals via Enzymatic Cascade
TGF - β Signaling Pathway
Activation and Inactivation of G Proteins
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Intracellular Signaling Affects Focal Adhesions
Some...
GPCRs Regulate Adenylyl Cylase Activity